418 related articles for article (PubMed ID: 25969152)
1. A Systematic Review of the Economic and Humanistic Burden of Gout.
Shields GE; Beard SM
Pharmacoeconomics; 2015 Oct; 33(10):1029-47. PubMed ID: 25969152
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy.
Wu EQ; Forsythe A; Guérin A; Yu AP; Latremouille-Viau D; Tsaneva M
Am J Ther; 2012 Nov; 19(6):e157-66. PubMed ID: 21317625
[TBL] [Abstract][Full Text] [Related]
3. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.
Khanna PP; Nuki G; Bardin T; Tausche AK; Forsythe A; Goren A; Vietri J; Khanna D
Health Qual Life Outcomes; 2012 Sep; 10():117. PubMed ID: 22999027
[TBL] [Abstract][Full Text] [Related]
4. The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
Meacock R; Dale N; Harrison MJ
Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of gout: A systematic review.
Rai SK; Burns LC; De Vera MA; Haji A; Giustini D; Choi HK
Semin Arthritis Rheum; 2015 Aug; 45(1):75-80. PubMed ID: 25912932
[TBL] [Abstract][Full Text] [Related]
6. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review.
Ismaila AS; Sayani AP; Marin M; Su Z
BMC Pulm Med; 2013 Dec; 13():70. PubMed ID: 24304726
[TBL] [Abstract][Full Text] [Related]
7. The Economic and Humanistic Burden of Severe Sepsis.
Tiru B; DiNino EK; Orenstein A; Mailloux PT; Pesaturo A; Gupta A; McGee WT
Pharmacoeconomics; 2015 Sep; 33(9):925-37. PubMed ID: 25935211
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.
Nellesen D; Yee K; Chawla A; Lewis BE; Carson RT
J Manag Care Pharm; 2013; 19(9):755-64. PubMed ID: 24156644
[TBL] [Abstract][Full Text] [Related]
9. Clinical, humanistic, and economic outcomes of gout.
Brixner DI; Ho MJ
Am J Manag Care; 2005 Nov; 11(15 Suppl):S459-64; quiz S465-8. PubMed ID: 16300460
[TBL] [Abstract][Full Text] [Related]
10. Humanistic and cost burden of systemic sclerosis: A review of the literature.
Fischer A; Zimovetz E; Ling C; Esser D; Schoof N
Autoimmun Rev; 2017 Nov; 16(11):1147-1154. PubMed ID: 28899803
[TBL] [Abstract][Full Text] [Related]
11. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.
Jackson R; Shiozawa A; Buysman EK; Altan A; Korrer S; Choi H
BMJ Open; 2015 Jun; 5(6):e007214. PubMed ID: 26109113
[TBL] [Abstract][Full Text] [Related]
12. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
Ruoff G; Edwards NL
Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
[TBL] [Abstract][Full Text] [Related]
13. A systematic literature review on the health-related quality of life and economic burden of Fabry disease.
Jovanovic A; Miller-Hodges E; Castriota F; Takyar S; Howitt H; Ayodele O
Orphanet J Rare Dis; 2024 Apr; 19(1):181. PubMed ID: 38689282
[TBL] [Abstract][Full Text] [Related]
14. The economic impact of gout: a systematic literature review.
Trieste L; Palla I; Fusco F; Tani C; Baldini C; Mosca M; Turchetti G
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S145-8. PubMed ID: 23072897
[TBL] [Abstract][Full Text] [Related]
15. Chronic gout: epidemiology, disease progression, treatment and disease burden.
Brook RA; Forsythe A; Smeeding JE; Lawrence Edwards N
Curr Med Res Opin; 2010 Dec; 26(12):2813-21. PubMed ID: 21050059
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
Bereza BG; Machado M; Einarson TR
Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
[TBL] [Abstract][Full Text] [Related]
17. The economic burden of uncontrolled gout: how controlling gout reduces cost.
Flores NM; Nuevo J; Klein AB; Baumgartner S; Morlock R
J Med Econ; 2019 Jan; 22(1):1-6. PubMed ID: 30289009
[TBL] [Abstract][Full Text] [Related]
18. Humanistic and economic burden of generalized anxiety disorder in North America and Europe.
Revicki DA; Travers K; Wyrwich KW; Svedsäter H; Locklear J; Mattera MS; Sheehan DV; Montgomery S
J Affect Disord; 2012 Oct; 140(2):103-12. PubMed ID: 22154706
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
